Patent application number | Description | Published |
20100294047 | METHOD AND SYSTEM FOR PERFORMING A MAGNETIC SEPARATION PROCEDURE - Methods, systems, and apparatus are provided for automated isolation of selected analytes, to which magnetically-responsive solid supports are bound, from other components of a sample. An apparatus for performing an automated magnetic separation procedure includes a mechanism for effecting linear movement of a magnet between operative and non-operative positions with respect to a receptacle device. A receptacle holding station within which a receptacle device may be temporarily stored prior to moving the receptacle to the apparatus for performing magnetic separation includes magnets for applying a magnetic field to the receptacle device held therein, thereby drawing at least a proton of the magnetically-responsive solid supports out of suspension before the receptacle device is moved to the magnetic separation station. An automated receptacle transport mechanism moves the receptacle devices between the apparatus for performing magnetic separation and the receptacle holding station. | 11-25-2010 |
20110053169 | METHOD FOR CONTINUOUS MODE PROCESSING OF THE CONTENTS OF MULTIPLE REACTION RECEPTACLES IN A REAL-TIME AMPLIFICATION ASSAY - An automated analyzer for performing multiple diagnostic assays simultaneously includes multiple stations in which discrete aspects of the assay are performed on fluid samples contained in sample vessels. The analyzer includes stations for automatically preparing a sample, incubating the sample, preforming an analyte isolation procedure, ascertaining the presence of a target analyte, and analyzing the amount of a target analyte. An automated receptacle transporting system moves the sample vessels from one station to the next. A method for performing an automated diagnostic assay includes an automated process for isolating and amplifying a target analyte, and, in one embodiment, a method for real-time monitoring of the amplification process. | 03-03-2011 |
20110147610 | SYSTEM FOR CONTINUOUS MODE PROCESSING OF THE CONTENTS OF MULTIPLE REACTION RECEPTACLES IN A REAL-TIME AMPLIFICATION ASSAY - An automated analyzer for performing multiple diagnostic assays simultaneously includes multiple stations in which discrete aspects of the assay are performed on fluid samples contained in sample vessels. The analyzer includes stations for automatically preparing a sample, incubating the sample, preforming an analyte isolation procedure, ascertaining the presence of a target analyte, and analyzing the amount of a target analyte. An automated receptacle transporting system moves the sample vessels from one station to the next. A method for performing an automated diagnostic assay includes an automated process for isolating and amplifying a target analyte, and, in one embodiment, a method for real-time monitoring of the amplification process. | 06-23-2011 |
20130026079 | METHOD AND SYSTEM FOR PERFORMING A MAGNETIC SEPARATION PROCEDURE - Methods, systems, and apparatus are provided for automated isolation of selected analytes, to which magnetically-responsive solid supports are bound, from other components of a sample. An apparatus for performing an automated magnetic separation procedure includes a mechanism for effecting linear movement of a magnet between operative and non-operative positions with respect to a receptacle device. A receptacle holding station within which a receptacle device may be temporarily stored prior to moving the receptacle to the apparatus for performing magnetic separation includes magnets for applying a magnetic field to the receptacle device held therein, thereby drawing at least a proton of the magnetically-responsive solid supports out of suspension before the receptacle device is moved to the magnetic separation station. An automated receptacle transport mechanism moves the receptacle devices between the apparatus for performing magnetic separation and the receptacle holding station. | 01-31-2013 |
20150027933 | SYSTEM FOR PERFORMING A MAGNETIC SEPARATION PROCEDURE - A system for separating an analyte from other components of a sample contained in a receptacle, where the system includes a receptacle holding station and a magnetic separation station. The receptacle holding station is configured to receive and hold a receptacle and includes one or more magnets positioned to apply a magnetic field to the contents of the receptacle. When present in the receptacle holding station, a receptacle remains stationary relative to the one or more magnets. The magnetic separation station includes one or more magnets and is constructed and arranged to perform a magnetic separation procedure on the contents of a receptacle transported from the receptacle holding station to the magnetic separation station by an automated receptacle transport. The magnetic separation procedure includes isolating an analyte immobilized on a magnetically-responsive solid support within the receptacle and removing other components of the sample from the receptacle. The magnetic separation station is configured to provide relative movement between the receptacle and the one or more magnets after the receptacle is transported to the magnetic separation station. | 01-29-2015 |
20160124005 | SYSTEM FOR PERFORMING A MAGNETIC SEPARATION PROCEDURE - A system for separating an analyte from other components of a sample includes a receptacle holding station and a magnetic separation station. The receptacle holding station includes one or more stationary, permanent magnets positioned to apply a magnetic field to the contents of a receptacle held stationary within the receptacle holding station. The magnetic separation station includes one or more permanent magnets and is configured to perform a magnetic separation procedure on the contents of a receptacle transported from the receptacle holding station to the magnetic separation station. The magnetic separation procedure includes isolating an analyte immobilized on a magnetically-responsive solid support within the receptacle and removing other components of the sample from the receptacle. The magnetic separation station is configured to provide relative movement between the receptacle and the one or more permanent magnets after the receptacle is transported to the magnetic separation station. | 05-05-2016 |
Patent application number | Description | Published |
20130131608 | POSITIVE BOLUS CLAMP - A clamp for clamping flexible tubing is disclosed. The clamp includes a body having a first portion, a second portion, a first passage through the first portion, and a second passage through the second portion. The first passage is configured to compress a first length of the flexible tubing when the flexible tubing is displaced laterally into the first passage. The second passage is configured to compress a second length of the flexible tubing that does not overlap the first length when the flexible tubing is displaced laterally into the second passage. | 05-23-2013 |
20150250947 | Syringe Flush Protection Valve and Method - A system and a method are adapted for assessing the patency of a fluid infusion line connected to a patient, a source of medicant, and a pump. The system is configured for injecting a fluid into the fluid pressure line using a syringe, determining whether the syringe exhibits a resistance to fluid being injected into a the fluid line and, if no resistance is exhibited, monitoring the pump to verify whether the pump exhibits an alarm that indicates a check valve has been opened. | 09-10-2015 |
20150250995 | POSITIVE BOLUS CLAMP - A clamp for clamping flexible tubing is disclosed. The clamp includes a body having a first portion, a second portion, a first passage through the first portion, and a second passage through the second portion. The first passage is configured to compress a first length of the flexible tubing. The second passage is configured to compress a second length of the flexible tubing that does not overlap the first length. | 09-10-2015 |
Patent application number | Description | Published |
20130056130 | SYSTEM AND METHOD FOR JOINT INTEGRITY DETECTION - An inspectable joint in a medical device is disclosed that includes at least one medical-grade tube having an end, a medical-grade fitting having at least one joining surface configured to accept the end of the tube, and a joining material disposed between the tube and the joining surface. The joining material includes a first component configured to couple the tube to the fitting and a second component configured to provide observable evidence of the presence of the joining material between the tube and the joining surface. | 03-07-2013 |
20130066273 | LOW-FORCE PUMPING SEGMENT - A pumping segment having a low shut-off force is disclosed. The pumping segment includes a tube having an interior surface with at least two notches on opposite sides of the interior surface. | 03-14-2013 |
20140276415 | INFUSION SYSTEM WITH DUAL-CHAMBERED RESERVOIR - Described herein are medical fluid infusion systems for pumping a fluid to a patient, such as in a hospital environment. In one aspect, disclosed is an infusion system including a drive assembly having a drive fluid reservoir and a drive mechanism configured to apply a force to drive fluid from the drive fluid reservoir through a length of tubing. The infusion system includes a hydraulic assembly having a first fluid chamber having an inlet port configured to be in fluid communication with the length of tubing and a second fluid chamber having an outlet port configured to be in fluid communication with a patient extension set and a flexible movable divider sealing the first fluid chamber from the second fluid chamber. Related apparatus, systems, techniques and articles are also described. | 09-18-2014 |
20140276424 | Pump Segment Placement - A pump cassette is configured for coupling with a pump device. The pump cassette may include a fluid lumen adapted for passage and propulsion of an infusion fluid toward a patient; a valve assembly that can be actuated to regulate fluid flow through the fluid lumen; and a frame coupled to the fluid lumen and the valve assembly. The frame is adapted to be inserted into a seat of a pump device. The frame is configured to be inserted into the seat only when aligned in a predetermined orientation relative to the seat. | 09-18-2014 |
20140339814 | SYSTEM AND METHOD FOR JOINT INTEGRITY DETECTION - An inspectable joint in a medical device is disclosed that includes at least one medical-grade tube having an end, a medical-grade fitting having at least one joining surface configured to accept the end of the tube, and a joining material disposed between the tube and the joining surface. The joining material includes a first component configured to couple the tube to the fitting and a second component configured to provide observable evidence of the presence of the joining material between the tube and the joining surface. | 11-20-2014 |
Patent application number | Description | Published |
20090155389 | Selective serotonin receptor inverse agonists as therapeutics for disease - Disclosed herein are pharmaceutical compositions comprising an inverse serotonin receptor agonist or a serotonin receptor antagonist and an anti-psychotic agent. Disclosed herein are also methods of treating psychotic disorders using the disclosed pharmaceutical compositions. | 06-18-2009 |
20090209525 | ENABLING METHODS TO IDENTIFY ALLOSTERIC MODULATORS OF RECEPTOR ACTIVITY - A method developed to identify receptor modulators, involving providing a mutant receptor, wherein said mutant receptor has a mutation that alters the activity of said mutant receptor compared to a wild type receptor; contacting said mutant receptor with a candidate compound; and determining whether said candidate compound modulates the activity of said mutant receptor. | 08-20-2009 |
20100227885 | Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases - Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis. | 09-09-2010 |
20100227886 | Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases - Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis. | 09-09-2010 |
20110257229 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES - Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis. | 10-20-2011 |
20120277221 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES - Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis. | 11-01-2012 |
20130137727 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES - Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis. | 05-30-2013 |
20140140982 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES - Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis. | 05-22-2014 |
20150202194 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES - Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis. | 07-23-2015 |
Patent application number | Description | Published |
20100113993 | FORCE-MULTIPLYING PERCUSSOR - The invention is a percussor comprising an anvil, a hammer, a coil, and a pulse generator. The anvil is equipped with a force-receiving surface and a force-delivering surface which are rigidly connected together, the force-delivering surface being intended for contact with a patient's body. The hammer is also equipped with a force-receiving surface and a force-delivering surface, the hammer being attached to the anvil in such a way that the hammer's force-delivering surface and the anvil's force-receiving surface are mechanically free to come together or move apart. The coil forces the hammer's force-delivering surface and the the anvil's force-receiving surface to separate when the coil is energized with an electrical current. The pulse generator supplies repeated electrical current pulses to the coil which causes repeated impulse forces to be applied to a patient's body whenever the technician applies a continuing force to the hammer's force-receiving surface. | 05-06-2010 |
20130046215 | FORCE-MULTIPLYING PERCUSSOR AND SELF-APPLICATOR SYSTEM FOR AIRWAY CLEARANCE - An airway clearance combines a force multiplying percussor and a self-applicator assembly. The percussor has an anvil, a hammer, a coil, and a pulse generator. The anvil has a force receiving surface and a force delivering surface. The hammer also has a force-receiving surface and a force-delivering surface, and is attached to the anvil such that the hammer's force delivering surface and the anvil's force receiving surface are mechanically free to come together or move apart. When energized with an electrical current, the coil forces the hammer's force delivering surface and the anvil's force receiving surface to separate. The pulse generator supplies pulses of electrical current to the coil. | 02-21-2013 |
20130245516 | SELF-APPLICATOR FOR AN AIRWAY CLEARANCE DEVICE - A self-applicator for a percussor or airway clearance device has first and second straps that overlay one another and define an open area in-between. A pouch for holding the percussor is secured in the open area. Handles on the ends of the straps permit a user to easily hold the self-applicator against his/her back while using the percussor. One of the handles has an adjustable length harness to accommodate users of different sizes. An application surface on one of the straps is configured to make contact with the user's back and permit the percussor to contact the user's back through the strap. | 09-19-2013 |